Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Boyd

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Targeting cancer using fragment based drug discoveryAndrew P Turnbull, Susan M Boyd
Neoplasia (New York, N.Y.)|August 12, 2019
A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length RegulationAlan E Bilsland, Yu Liu, Andrew Turnbull, et al.
BMC Genomics|October 6, 2010
Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesotheliomaKyle Lafferty-Whyte, Alan Bilsland, Claire J Cairney, et al.
Journal of Medicinal Chemistry|March 25, 2008
Molecular characterization of macbecin as an Hsp90 inhibitorChristine J Martin, Sabine Gaisser, Iain R Challis, et al.
Journal of Medicinal Chemistry|September 20, 2008
Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitorsMing-Qiang Zhang, Sabine Gaisser, Mohammad Nur-E-Alam, et al.
Journal of Medicinal Chemistry|October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase ThetaMartin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Targeting cancer using fragment based drug discoveryAndrew P Turnbull, Susan M Boyd
Neoplasia (New York, N.Y.)|August 12, 2019
A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length RegulationAlan E Bilsland, Yu Liu, Andrew Turnbull, et al.
BMC Genomics|October 6, 2010
Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesotheliomaKyle Lafferty-Whyte, Alan Bilsland, Claire J Cairney, et al.
Journal of Medicinal Chemistry|March 25, 2008
Molecular characterization of macbecin as an Hsp90 inhibitorChristine J Martin, Sabine Gaisser, Iain R Challis, et al.
Journal of Medicinal Chemistry|September 20, 2008
Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitorsMing-Qiang Zhang, Sabine Gaisser, Mohammad Nur-E-Alam, et al.
Journal of Medicinal Chemistry|October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase ThetaMartin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Pageof 1